Scoparone could reverse the changes of these protein ratios, suggesting its inhibitory effect on the activation of JNK/Sab signaling pathway in the liver of NASH mice. This evidence concerns the gene SH3BP5 and metabolic dysfunction-associated steatohepatitis.